---
schema_version: "secwatch.filing_event.v1"
accession: "0001326190-24-000036"
form_type: "8-K"
ticker: "ALT"
cik: "0001326190"
company_name: "Altimmune, Inc."
filed_at: "2024-08-15T23:59:59+00:00"
generated_at: "2026-05-31T08:58:33.490239+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Altimmune director David Drutz will not stand for re-election at 2024 annual meeting

## Summary
- David J. Drutz, M.D. notified the Board that he will not stand for re-election at the 2024 Annual Meeting of Shareholders.
- Drutz will continue as a director until the date of the Annual Meeting; his decision is not due to any disagreement with the company.
- The Board thanked Dr. Drutz for his service; no replacement has been announced as he will not stand for re-election.

## SEC filing metadata
- accession: 0001326190-24-000036
- form_type: 8-K
- ticker: ALT
- cik: 0001326190
- company_name: Altimmune, Inc.
- filed_at: 2024-08-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326190/000132619024000036/0001326190-24-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326190/000132619024000036/alt-20240813x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001326190-24-000036
- JSON: https://secwatch.observer/filing/0001326190-24-000036.json
- Plain text: https://secwatch.observer/filing/0001326190-24-000036.txt

## Key facts
- Executive change
  David J. Drutz departed as Director at Altimmune, Inc..
  - Action: decided not to stand for re-election
  - Role: Director
  source text: On August 13, 2024, David J. Drutz, M.D. notified the Board of Directors (the “Board”) of Altimmune, Inc. (the “Company”) that he has decided not to stand for re-election to the Board at the Company’s 2024 Annual Meeting of Shareholders (the “Annual Meeting”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326190/000132619024000036/0001326190-24-000036-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.